Kidney Check: Home Urine Test
As seen on App Store
- Last update
7 months ago
Current version 9.18.1
Argentina, Brazil, Canada, Chile, Colombia, Israel, Mexico, Peru, and US
TherAppX Review Guidance v2022.10
Review update 2023-02-16
Context informing the intended clinical use of the app based on the targeted health conditions and included features.
Covered health conditions
The developer claims to offer features targeting these health conditions.
Features that facilitate health data generation, collection, sharing and interpretation by patients.
- Manual monitoring
- Patients can manually record information about their health (e.g. blood pressure data, anxiety assessments, mood journals, etc.).
- Diagnostic support based on data
- Patients can be informed of the presence or absence of a health problem based on interpretation of their recorded health data.
Features that promote self-care and self-management of conditions.
- Chatbot interventions
- Patients may interact with an automated agent to achieve their health goals.
The app must show relevance of its clinical underpinnings as determined by scientific evidence and support from clinicians or reputable organizations.
Evidence of acceptability or feasibility
A point is provided to this app if there is at least one peer-reviewed study demonstrating the app's acceptability, as found on a research database (e.g. Pubmed, Medline). The evidence is in the form of a clinical trial, a feasibility study, a review, a survey or other published evidence.
Dipping at home: is it better, easier, and more convenient? A feasibility and acceptability study of a novel home urinalysis using a smartphone application.
- Pediatr Nephrol, 2022-04-22
- Erez DL, Derwick H, Furth S, Ballester L, Omuemu S, Adiri Y, Mink J, Denburg M
Remote digital urinalysis with smartphone technology as part of remote management of glomerular disease during the SARS-CoV-2 virus pandemic: single-centre experience in 25 patients.
- Clin Kidney J, 2022-05-03
- Stauss M, Dhaygude A, Ponnusamy A, Myers M, Woywodt A
Feasibility and acceptability of home use of a smartphone-based urine testing application among women in prenatal care.
- Am J Obstet Gynecol, 2019-07-14
- Burke AE, Thaler KM, Geva M, Adiri Y
Licensed by a regulatory organization
A point is provided to this app if it is licensed by at least one regulatory organization (e.g. FDA, European Union, Health Canada). A regulatory decision means that a regulatory body has approved marketing for medical purposes after assessing supporting evidence and the tool's safety.
- Food and Drug Administration - Class II
- Device for which general controls are insufficient to provide reasonable assurance of the safety and effectiveness of the device.
Developed by a clinician
A point is provided to this app if health professionals are involved in its development.
Recommended by an independent organization
A point is provided to this app if it is recommended by at least one independent non-regulatory organization, such as health technology assessment agencies, government, clinical association or research institution.
No recommendation found
Clinical value demonstrated by a peer-reviewed study
A point is provided to this app if there is at least one peer-reviewed study proving the app's clinical value, as found in a research database (e.g. Pubmed, Medline). The evidence is in the form of a clinical trial or other published clinical evidence.
Improving proteinuria screening with mailed smartphone urinalysis testing in previously unscreened patients with hypertension: a randomized controlled trial.
- BMC Nephrol, 2019-04-20
- Leddy J, Green JA, Yule C, Molecavage J, Coresh J, Chang AR
Economic value demonstrated by a peer-reviewed study
A point is provided to this app if there is at least one peer-reviewed study proving the app's economic value, as found in a research database (e.g. Pubmed, Medline). The evidence is in the form of an economic study such as a cost-effectiveness analysis.
No demonstration found
Other study of interest
Other studies providing additional context that may be considered for decision-making. This information does not affect the clinical robutness score.
No demonstration found
The app must not disclose personal information from users. Score is based on public information. A high score does not guarantee absence of issues with privacy.
Restricted access to accounts
A point is provided to this app if it does not give information about other apps installed on the device (creator, name, type of account, etc.).
Restricted access to unique device identification
A point is provided to this app if it does not give information about the device's hardware components, which could be used to track the user on different web services.
Restricted access to the phone subscriber identity (SIM)
A point is provided to this app if it does not give information about the mobile phone services and provider, which could be used to track the user on different messaging and phone services.
Restricted access to phone number
A point is provided to this app if it does not give information on the phone number, which could be used to follow the user on services that use this data or to attack using spam, phishing or two-factor authentication (2FA) tactics.
Right to be forgotten
Data privacy officer contact available
Data privacy legislation
- HIPAA (United States)
- GDPR (Europe)
- DPA (UK)
This information does not affect the privacy score.
This app requests access to some features of your device. Make sure that each of these accesses is relevant to you. This information does not affect the privacy score.
- Allows the app to take pictures, record videos and use a live output of the camera view.
- Photo library
- Allows the app to access photos, media and files on your device.
The app must not be exposed to external security threats. Score is based on public information. A high score does not guarantee absence of issues with security.
A point is provided to this app if it has been updated at least 1 time in the last 6 months, significantly reducing technical vulnerability and associated risks.
Restricted access to device administrator privileges
A point is provided to this app if it cannot gain administrator access to your device.
Restricted access to device debugging details
A point is provided to this app if it cannot gain debugging access to your device, which could expose privileged details and sensitive information.
Compliant to one or more security certification
A point is provided to this app if it declares compliance with one or more security certifications (e.g. ISO/IEC 27017, ISO 27001, PCI, SOC 2, HITRUST, MASVS).
- HITRUST CSF
- HITRUST CSF is a prescriptive set of controls that meet the requirements of multiple regulations and standards.
- ISO 27001
- International standard on how to manage information security certification, provided by external audits. It aims to help manufacturers make the information assets they hold more secure.
Easy to understand
A point is provided to this app if it is easy to understand (grade level below 8) as defined by the Automated Readability Index (ARI) readability tool.
User satisfaction on App Store
A point is provided to this app if user satisfaction averaged at least 4 out of 5 stars on App Store.
- App Store
Free of distracting ads
A point is provided to this app if it is free of unrelated ads during app use.
Sufficient support section
A point is provided to this app if it provides appropriate resources to adequately help users who experience problems with the app (e.g. support section, knowledge base, FAQs).
Compliant to a design standard
A point is provided if the app manufacturer declares compliance with one or more design standard(s) related to accessibility, usability, and inclusivity (e.g. ISO 9241, WCAG, ADA, etc.).
- WCAG 2.1 AA
- Web Content Accessibility Guidelines (WCAG) version 2.1 explains how to make web content more accessible to people with disabilities. Level A is the minimum level.